Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case report
ConclusionsThis is the first report of ILH induced by pembrolizumab in a patient with lung adenocarcinoma.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Arthritis | Cancer | Cancer & Oncology | Gastroenterology | Histiocytosis | Immunotherapy | Liver | Lung Cancer | Non-Small Cell Lung Cancer | Palliative | Rheumatoid Arthritis | Rheumatology | Skin | Skin Biopsy | Urology & Nephrology